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Abstract
BACKGROUND: Anemia during pregnancy is still a challenge throughout the world, and it may cause severe health 
consequences in the maternal and fetal sides. 
AIM: This study aims to find out the prevalence of maternal anemia and potential adverse outcomes in Iraq.
METHODS: In Medical City Tertiary Center in Baghdad, singleton pregnant ladies came for delivery were involved over 
6 months’ period. Based on hemoglobin (Hb) readings; they were divided into no anemia group (Hb>11 g/l) and anemia 
group which were further subdivided into mild, moderate, and severe (Hb =10–10.9, =7.1–9.9, and <7 g/l, respectively). 
Full history and examination were performed by attending obstetrician and pediatrician for the upcoming babies.
RESULTS: Maternal anemia prevalence was 84.84% out of 4473 cases. No anemia group was 15.16%, mild 
40.73%, and moderate 40.73%, while severe anemia group (24.93%). Maternal occupation, educational status, 
and Hb levels were significantly associated with anemia (p < 0.001), unlike parity, body mass index, and delivery 
mode. Neonatal preterm delivery, birth weight and length, small for gestational age (SGA), Apgar score, respiratory 
distress, and high death rate were strongly related to mothers’ anemia (p < 0.001), on the contrary of septicemia, birth 
asphyxia, and hypoglycemia, in spite of their higher frequency rates in anemia groups. Birth weight, and length, and 
gestational age were lowered significantly in moderate and severe anemia, while Apgar score was low throughout all 
anemia categories. SGA was significant in severe anemia.
CONCLUSION: Maternal anemia is highly prevalent in Iraq with significant adverse neonatal events and elevated 
rates of mortality.
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Introduction
Anemia during pregnancy is a distinct health 
issue throughout the world, with a special focus in the 
third world and low- and middle-income populations. 
People from Africa, Southeast Asia, and Mediterranean 
areas are at higher risk of anemia [1], [2].
Poor nutritional status such as iron and folic 
acid deficiency is one of the main causes of maternal 
anemia in addition to physiological etiologies [3], [4], [5].
Globally, anemia is present in 14–75% of 
pregnant mothers in developing countries, while the 
percentage is 16–29% in developed countries. More 
than half of pregnant ladies develop anemia without 
supplements [6], [7], [8].
Anemia within pregnancy may lead to adverse 
birth outcomes including (but not limited to) prematurity, 
low birth weight (LBW), and neonatal mortality [9], [10].
There are wide variations in maternal anemia 
burden between various geographical distributions, and 
even within the same region so that it is vital to study 
population factor in specific areas to study maternal 
anemia and pregnancy outcomes in different parts of 
the world, aiming to offer some data to the involved 
health authorities to put effective strategies trying to 
prevent anemia during pregnancy and improve its 
outcomes [11], [12].
We aimed at this study to find out the 
prevalence of anemia in pregnant mothers and the 
possible neonatal consequences in Iraq.
Materials and Methods
Patients’ data
Throughout the 6 months’ data collection period 
(from January 2, 2019, to July 1, 2019), all singleton 
pregnant ladies presented with labor to the Department 
of Obstetrics and Gynecology at Medical City Hospital 
in Baghdad, the capital of Iraq country, were involved. 
It is the biggest specialized tertiary obstetrical center in 
Iraq that receives cases from all over the country.
Mothers with systemic diseases or abnormalities 
such as hemoglobinopathies (such as thalassemia 
and sickle cell anemia), diabetes, hypertension, renal 
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problems, smoking, and oligo- or polyhydramnios were 
excluded from the study.
Detailed medical history was taken by the 
attending obstetrician, and recorded within hospital files, 
including the age of pregnant women, gestational age 
(using the date of last cycle, and/or as early as possible 
ultrasound examination), parity, occupation, educational 
status, and delivery mode. Weight was measured in 
kilograms (kg), and height in meters (m) to calculate the 
body mass index (BMI), which equals to kg/m2. Blood 
was taken to measure hemoglobin (Hb) concentration 
performed by coulter counter approach. Cases with Hb 
levels >11 g/l (gram per liter) were considered normal and 
no anemia could be defined, while anemia is documented 
when Hb <11 g/l and divided into three categories, 
Hb = 10–10.9 g/l was the mild anemia group, Hb = 7.1–
9.9 g/l was assumed to have moderate anemia, and Hb 
<7 g/l was related to the severe anemia group [13].
After delivery, the neonates were examined 
by the attending pediatrician and sent for blood sugar 
routinely according to the hospital policy. All findings 
were put down in the medical records. LBW was 
considered when birth weight <2500 g, while small 
for gestational age (SGA) was defined as birth weight 
<3rd percentile for gestation, and preterm delivery took 
place before completed 37 weeks of gestation [14].
Neonatal septicemia was confirmed by 
positive findings of blood culture, the definition of birth 
asphyxia was met when Apgar score <6 at 5 min [15], 
and neonatal blood sugar of <40 mg/dl was named as 
hypoglycemia [16]. Newly delivered babies with their 
mothers were followed up closely until hospital discharge 
or death (if any). Informed consent was obtained from 
all participants. Institutional Review Boards at Al-Kindy 
College of Medicine, and College of Medicine, at the 
University of Baghdad approved this research. Work 
was done in accordance with the Helsinki Declaration.
Statistical analysis
Statistical Package for the Social Sciences 
(SPSS) version 22 (IBM Corp., Armonk, NY, USA) 
was used to complete statistical analysis. Chi-square 
and Fisher’s Exact tests were utilized for categorical 
data, while continuous data were analyzed using 
unpaired t-test. p ≤ 0.05 was considered as statistically 
significant. Mean± standard deviation (SD) was used 
for data expression.
Anemia consequences were separated from the 
effects of possible confounders using linear regression 
analysis to foresee continuous outcomes such as birth 
weight and length of gestation, while analysis of logistic 
regression was done to predict categorical results such 
as SGA and neonatal death.
The analysis of regression included the major 
influence of Hb as a continuous event. The binary 
analysis was performed between Hb (continuous 
variable) and all other possible foretellers in all 
analyses, and preceding selections were applied to 
localize covariates and interaction expressions to be 
included in regression patterns. Only occupation and 
age of mothers were regarded as covariates within all 
analyses of regression whatever the significant level 
was, because of their likely confounding effect.
Results
Total number (n) of involved cases was 4473 
pregnant women; their mean age was 24±57 years 
ranging from 14 to 43 years. Normal Hb level (>11 g/l) 
was found in 678 women (15.16%), mild anemia 
group had 858 cases (19.18%), moderate anemia 
was observed in 1822 (40.73%), and severe anemia 
group involved 1115 ladies (24.93%). The prevalence of 
maternal anemia in all groups was 84.84%.
Parity, BMI, and delivery mode were not found 
to be significantly associated with maternal anemia, 
unlike occupation, educational status, and Hb levels, 
as shown in Table 1.
Regarding neonatal outcomes, preterm 
delivery, birth weight and length, SGA, and Apgar score 
(at 1 and 5 min) were significantly related to maternal 
anemia, as shown in Table 2. However, all the above 
parameters were worse with the severe anemia group, 
while the normal Hb group had the best results.
Respiratory distress and neonatal death were 
significantly associated with maternal anemia. Most 
Table 1: General maternal characteristics
Maternal variable Mild anemia 
(n, %)=858 (19.18%)
Moderate anemia 
(n, %)=1822 (40.73%)
Severe anemia 
(n, %)=1115 (24.93%)
Normal Hb 
(n, %)=678 (15.16%)
p-value
Maternal age in years (mean±SD) 24.33±2.6 23.92±4.1 25.20±3.4 24.85±1.6 0.732
Hemoglobin (g/dl), (mean±SD) 10.42.67±4.8 8.39±8.6 6.21±7.4 11.84±5.8 <0.001
Parity, primigravida: multigravida 276:582 624:11983 376: 739 221: 457 0.823
BMI, (mean±SD) 29.12±2.5 29.36±62 28.89±4.1 29.74±39 0.043
Occupation: n (%)
a) Employed: n (%)=1298 (29.02%) 307 (23.65) 281 (21.65) 108 (8.32) 602 (46.38) < 0.001
b) Housewife: n (%)=3175 (70.98%) 551 (17.35) 1541 (48.54) 1007 (31.72) 76 (2.39)
Educational status:
a) Primary school level or higher: n (%)=1562 (34.92%) 483 (30.92) 389 (24.90) 126 (8.07) 564 (36.11) < 0.001
b) Below primary school level: n (%)=2911 (65.08%) 375 (12.88) 1433 (49.23) 989 (33.97) 114 (3.92)
Delivery mode: n (%)
Cesarean section (CS): n (%)=3126 (69.89%) 635 (20.31) 1176 (37.62) 596 (19.07) 719 (23.00) 0.172
Normal vaginal: n (%)=1347 (30.15%) 223 (16.55) 396 (29.40) 469 (34.82) 259 (19.23) 0.693
BMI: Body mass index.
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of respiratory distress cases were preterm (n = 325, 
90.03%, p < 0.001), and most of neonatal mortality 
was due to respiratory distress not responded to 
management (n = 221, 59.41%, p < 0.001).
Other complications such as septicemia, 
birth asphyxia, and hypoglycemia were not related 
significantly to anemia. Nevertheless, most of these 
complications were more frequent within the severe 
anemia group, and except birth asphyxia. These 
findings are evident in Table 3.
Table 4 is designed to look deeper into neonatal 
outcomes in relation to categories of maternal anemia. 
Birth weight (g) was decreased in both moderate and 
severe anemia groups (−83.11 g, p = 0.01; −507.72 g, 
p ≤ 0.001, respectively) when compared with normal 
Hb group.
Furthermore, birth length (cm) and gestational 
age (weeks) were significantly and progressively lower 
in moderate and severe anemia groups in comparison 
with normal Hb category (p values were decreased 
progressively with increasing anemia severity; as for birth 
length, p = 0.03 in moderate anemia and p ≤ 0.001 in 
severe anemia group, while it was p = 0.02 and p ≤ 0.001, 
respectively, in case of gestational age). However, Apgar 
score (at 1 min and 5 min) had statistically significant 
lower levels throughout all anemia groups compared with 
the normal Hb group. Finally, odds ratios of SGA were 
significantly higher in a severe group (p < 0.001). Some 
of these observations were associated with the influence 
of Hb on the age of gestation (weeks). After adjustment 
of this gestational age in regression analysis, we 
confirmed a negative association between Hb readings 
(continuous) and birth weight (kg), birth length (cm), 
Apgar score at 1 and 5 min, and SGA.
Discussion
The prevalence of maternal anemia at the time of 
delivery in our data was 84.84%, other local researchers 
found lower rates of 67% and 50.4% [17], [18]. This 
variance may be due to the wider range of drainage 
of patients to our hospital, as it receives cases from 
different cities inside the Iraqi borders, including rural and 
urban areas; this may give our results more reliability. In 
India and Pakistan, the prevalence rates were higher, 
reaching up to 89.6% and 90.5%, respectively [19], [20], 
but lower in Switzerland 18.5%, confirming the fact 
that suggests a distinct increase in maternal anemia in 
developing countries [21].
Herein this study, moderate anemia was higher 
than mild anemia. This finding was approved by some 
Indian scientists [19], but opposed by others whom 
stated higher rates of mild anemia followed by moderate 
and severe anemia according to the geographical and 
cultural backgrounds [20]. Iraqi people usually consume 
large amounts of black tea daily (which is considered as 
the second most popular drink after water in Iraq) that 
affect iron absorption, resulting in higher rates of more 
severe anemia [22], [23].
Employment and educational status was 
inversely related to anemia in our patients, in line with 
data collected from Thailand and Russia [24], [25].
Maternal anemia in our sample showed a 
significant negative effect on preterm delivery, birth 
weight and length, and Apgar scores at 1 and 5 min. 
Moreover, the higher the severity of maternal anemia, 
the lower the values of birth weight and length, 
independently from gestational age. These observations 
Table 2: General neonatal features
Neonatal variable Mild anemia 
(n, %)=858 (19.18%)
Moderate anemia 
(n, %)=1822 (40.73%)
Severe anemia 
(n, %)=1115 (24.93%)
Normal Hb 
(n, %)=678 (15.16%)
p-value
Preterm baby: n (%)=447 (9.99%) 35 (7.83) 116 (25.95) 267 (59.73) 29 (6.49) <0.001
Birth weight (g), (mean±SD) 3171.4±402.6 2863.5±342.1 2719.2±361.7 3346.8±327.3 <0.001
Birth length (cm), (mean±SD) 48.54±3.6 47.89±2.2 47.32±3.9 49.56±2.7 <0.001
SGA: n (%)=359 (8.03%) 62 (17.27) 67 (18.66) 69 (19.22) 161 (44.85) <0.001
Apgar score, (mean±SD) at:
1 min 7.7±1.3 7.4±1.1 6.9±0.8 7.9±1.6 <0.001
5 min 8.7±1.2 8.4±0.6 8.0±1.4 8.8±0.9 <0.001
SD: Standard deviation, SGA: Small for gestational age.
Table 3: Neonatal complications related to study groups
Neonatal complication, n (%) Mild anemia 
(n, %)=858 (19.18%)
Moderate anemia 
(n, %)=1822 (40.73%)
Severe anemia 
(n, %)=1115 (24.93%)
Normal Hb 
(n, %)=678 (15.16%)
p-value
Septicemia, 89 (1.99) 22 (24.72) 20 (22.47) 23 (25.84) 24 (26.97) 0.584
Respiratory distress, 361 (8.07) 68 (18.84) 101 (27.98) 159 (44.04) 33 (9.14) <0.001
Asphyxia, 96 (2.15) 25 (26.04) 24 (25.00) 23 (23.96) 24 (25.00) 0.532
Hypoglycemia, 541 (12.09) 137 (25.32) 120 (22.18) 136 (25.14) 148 (27.36) 0.210
Mortality, 372 (8.32) 30 (8.06) 82 (22.04) 226 (60.75) 34 (9.14) <0.001
Table 4: Neonatal complication for each category
Variable Mild anemia Moderate anemia Severe anemia
Diff. 95% CI p-value Diff. 95% CI p-value Diff. 95% CI p-value
Birth weight (g) −178.32 −286.12 91.82 0.14 −83.11 -223.42 −202.73 0.01 −507.72 −701.11 −323.11 <0.001
Birth length (cm) −0.21 −0.86 0.41 0.38 −1.97 -2.75 −0.52 0.03 −2.12 −2.84 −0.67 <0.001
Apgar score at 1 and 5 min −0.73 −0.97 -0.38 0.03 −0.79 -0.82 −0.03 0.01 −0.88 −0.93 −0.51 <0.001
Gestational age (weeks) −0.08 −0.42 0.53 0.34 −0.52 -0.49 −0.21 0.02 −0.47 −1.51 −0.06 <0.001
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
SGA 1.34 0.53 3.98 0.86 1.09 1.21 1.92 0.63 1.96 1.29 2.54 <0.001
*Bold Italic values represent differences and odds ratios which are statistically significant from normal Hb. OR: Odds ratio, CI: Confidence interval, SGA: Small for gestational age.
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were also found by other papers from Iran [26], 
Bangladesh [27], Scotland [28], and Brazil [29].
The occurrence of SGA in our data with severe 
anemia is agreed by other scientists, which may be 
caused by placental morphological changes that 
lead to hypoxia, oxidative stress, deficient nutritional 
transport, and increased the chance of fetal infection or 
inflammation [30], [31].
Regarding neonatal complications, we 
observed that neonatal respiratory distress was 
strongly associated with maternal anemia, which was 
in turn strongly linked to preterm delivery. This opinion 
was also adopted by many researchers [32], [33].
Other neonatal complications such as 
septicemia, hypoglycemia, and birth asphyxia were 
not related to maternal anemia in our neonates, as 
mentioned by papers came from different countries 
such as Egypt [34] and India [35].
The neonatal mortality rate in the involved 
cases was 8.32% which is nearer to the national 
figures 6–8.5% [36] and showed a significant relation 
with severe anemia in pregnancy, which was also 
found in Japan [37], and a recent systematic review 
and meta-analysis supported by the World Health 
Organization [38].
Our data have the power of prospective 
collection of a large sample of Iraqi pregnant women 
to evaluate the recent updated maternal anemia status 
in the Iraqi community, which suffer a lot from violence 
and wars in the previous years, this might affect the 
nutritional status and living conditions of pregnant 
mothers. Fortunately, our study environment and 
population have a great deal of similarity with most of 
the third world and limited income countries.
The weak point in this study that we measured 
Hb levels on delivery and did not evaluate time spent 
with anemia nor the cause of that anemia, whether 
nutritional or pathological. Furthermore, neonatal 
complications were followed up till patient discharge 
only, while some adverse events may occur remotely 
because of LBW or prematurity.
We hope these findings will trigger a more 
progressive work about maternal anemia to stand on 
the real situation regarding pregnant mothers and their 
babies in various parts of the globe, trying to put in 
effect preventive and management steps since it is a 
correctable disease.
Conclusion
The prevalence of maternal anemia was 
84.84%. It is significantly associated with preterm 
delivery, LBW and length, decreased Apgar score, 
neonatal respiratory distress, and high neonatal death 
rates. Early neonatal complications such as sepsis, 
asphyxia, and hypoglycemia had no relation with 
maternal anemia.
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